Standard Investments’s Boston Scientific BSX Stock Holding History

Standard Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-222,011	Closed	-$2.83M	–	175
2014 Q2	$2.83M	Hold	222,011	–	–	0.18%	63
2014 Q1	$3M	Buy	+222,011	New	+$2.91M	0.28%	59

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Standard Investments's BSX Position: Q3 2014 in Review

Standard Investments sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 222,011 shares — an estimated $2.83M sold.

Standard Investments first reported a position in BSX in Q1 2014 and held it in 2 quarters. The position peaked at $3M in Q1 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

Standard Investments reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
Standard Investments sold 222,011 Boston Scientific shares in Q3 2014, an estimated $2.83M.
Standard Investments first reported a position in Boston Scientific in Q1 2014 and held it in 2 quarters.
Standard Investments's Boston Scientific position peaked at $3M in Q1 2014.
437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Standard Investments's 13F filing for Q3 2014, filed 14 Nov 2014.